by Jason Hatch
Which cancer takes more American lives each year; prostate, colon, breast or lung cancer? Think about it for a minute. Got your guess? Would you be surprised to hear that lung cancer took over an estimated 160,000 lives in 2012? That’s more than prostate, pancreas, breast and colon cancer combined!
Do you know which cancer gets some of the least amount of funding? Take a look at the graph below.
As the figure shows, only $1,450 of Federal Research Funding per death was associated to lung cancer where $20,802 of Federal Research Funding per death was associated to breast cancer.
Ready for some facts:
- Lung cancer is the leading cancer killer in both men and women in the United States. In 1987, it surpassed breast cancer to become the leading cause of cancer deaths in women.
- Lung cancer is the most common cancer worldwide, accounting for 1.3 million deaths annually.
- The rate of new lung cancer cases (incidence) over the past 33 years has dropped for men (22% decrease), while it has risen for women (106% increase).
- Each year in the US, more than 228,000 people are diagnosed with lung cancer, and nearly 160,000 die of the disease.
- Between 20,000 and 30,000 people who have never smoked are diagnosed with Lung Cancer in the U.S. each year.
Let’s be honest, the ultimate goal here is to rid this planet of the disease labeled “Cancer” but this goal can’t be achieved without breaking it into smaller, more manageable, chunks. A good approach could be to put extra focus on the individual cancers that take the most lives. With lung cancer being the leading cancer in lost lives, it would be one to put extra focus on. Organizations like Free to Breathe and The National Lung Cancer Partnership exist to help support the ultimate goal of wiping this planet free of cancer and are taking the approach of focusing on the cancer that is taking the most lives, lung cancer.
Free to Breathe is an organization that typically creates run/walk events to help raise awareness and fundraise for lung cancer. All funds raise by Free to Breathe are sent to The National Lung Cancer Partnership.
The National Lung Cancer Partnership is focused on doubling the overall five-year lung cancer survival rate in the US by providing these key areas.
- Research to Help Fund the Next Scientific Breakthroughs
- Fully Understanding All Treatment Options
- Standardize Molecular Tumor Testing
- Increase the Number of Patients Participating in Clinical Trials
With 80 cents from every dollar raised, the National Lung Cancer Partnership is able to support the research, patient and physician education and public awareness in hopes to meet its goal of doubling the lung cancer survival by 2022 while keeping costs to a minimum.
Think about this; 1 in 13 men and 1 in 16 women will be diagnosed with lung cancer and only 16% of them will survive 5 years beyond their diagnosis. This survival rate needs to be a lot higher. Cornerstone is proud to help such an organization which is focused on improving these odds and giving those that are diagnosed a better chance at life.